| Name | Title | Contact Details |
|---|
We are the preferred digital transformation solution partner across businesses of all sizes and commercial industries. From a vertical perspective, we have industry leading insurance solutions for Commercial P&C and Specialty business supporting Carriers, MGAs and Brokers. This includes our new business platform that can be implemented in 90-120 days and leading low-code partner solutions for sales, submission, underwriting, claims, intelligent document processing and carrier integration. We also have industry expertise and services supporting Financial Services, other Insurance lines, Employee Benefits, and Healthcare transformation requirements. From a Cross-Industry or Horizontal perspective, Quess GTS utilizes the power of technology to drive productivity and enhance efficiency for our customers and business partners. We provide a range of digital integration solutions including low-code development platforms, automation, data analytics, AI/Generative AI, and core modernization solutions. Our approach to digital modernization and transformation includes a proven methodology from UI/UX, Mobile, Portal, Business Intelligence, Data Migration, and API Integration to the major core systems such as Salesforce.com, Oracle, Microsoft, Adobe, ServiceNow, and vertical specific application for policy administration, claims, and finance. We also have a world class Managed Services, Cyber Security, Cloud Migration, M365 migration and infrastructure support specializing in servicing small to medium sized organizations. Finally we have a partner ecosystem that can quickly scale support to meet spike staffing needs for M&A, start-up or scale-up scenarios where we can deploy global teams across various operational functions, customer experience and testing.
Apellis Pharmaceuticals is a global biopharmaceutical company based in Waltham, Massachusetts. The company is focused on developing innovative therapies that target the complement system, a crucial part of the immune system. Apellis aims to create life-changing treatments for various debilitating diseases through its commitment to scientific research and patient care. The company has a diverse pipeline of products, including EMPAVELI, which is approved for treating paroxysmal nocturnal hemoglobinuria and is being investigated for other conditions. SYFOVRE is in development for geographic atrophy, along with a combination therapy involving APL-APL-3007. Apellis is also exploring RNA therapies and gene-edited treatments for multiple therapeutic areas. With a global presence in countries such as the US, Canada, and several European nations, Apellis serves patients and healthcare providers affected by diseases related to the complement system. The company reported approximately $709 million in U.S. net product revenues for the full year 2024, reflecting its strong market position and commitment to advancing its therapeutic offerings.
Case Masters Inc is a Norcross, GA-based company in the Business Services sector.
Strauss Group Incorporated is a Williamsville, NY-based company in the Business Services sector.
Family Counseling Center is a Kennett, MO-based company in the Business Services sector.